Katayama, D., Yanagawa, M., Matsunaga, K., Watabe, H., Watabe, T., Kato, H., . . . Tomiyama, N. (2021). Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival. Nature Portfolio.
Cita Chicago Style (17a ed.)Katayama, Daisuke, et al. Greater Reductions in Blood Flow After Anti-angiogenic Treatment in Non-small Cell Lung Cancer Patients Are Associated with Shorter Progression-free Survival. Nature Portfolio, 2021.
Cita MLA (8a ed.)Katayama, Daisuke, et al. Greater Reductions in Blood Flow After Anti-angiogenic Treatment in Non-small Cell Lung Cancer Patients Are Associated with Shorter Progression-free Survival. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.